Cubist Systematic Strategies, LLC Imara Inc. Transaction History

Cubist Systematic Strategies, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.73 - $5.2 $47,744 - $66,560	12,800 New	12,800 $52,000
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.05 $26,961 - $48,531	-11,983 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $48,890 - $93,826	11,983 New	11,983 $49,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.